-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Evommune Initiates Phase 2B Clinical Trial Of Mrgprx2 Inhibitor Evo756 In Migraine Prophylaxis

路透·07/30/2026 12:08:19

登录查看新闻详情